Design and rationale of the TOTAL trial: A randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI - 26/02/14
, John Cairns, MD b, q, Salim Yusuf, MBBS, DPhil a, q, Brandi Meeks, MEng a, q, Olga Shestakovska, MSc a, q, Lehana Thabane, PhD a, q, Kari Niemelä, MD, PhD c, q, Philippe Gabriel Steg, MD d, q, Olivier F. Bertrand, MD, PhD e, q, Sunil V. Rao, MD f, q, Alvaro Avezum, MD, PhD g, q, Warren J. Cantor, MD h, q, Samir B. Pancholy, MD i, q, Raul Moreno, MD, PhD j, q, Anthony Gershlick, MBBS k, q, Ravinay Bhindi, MBBS, PhD l, q, Robert C. Welsh, MD m, q, Asim N. Cheema, MD, PhD n, q, Shahar Lavi, MD o, q, Michael Rokoss, MD a, q, Vladimír Džavík, MD p, qRésumé |
Background |
A major limitation of primary percutaneous coronary intervention (PPCI) for the treatment of ST-elevation myocardial infarction (STEMI) is impaired microvascular perfusion due to embolization and obstruction of microcirculation with thrombus. Manual thrombectomy has the potential to reduce distal embolization and improve microvascular perfusion. Clinical trials have shown mixed results regarding thrombectomy.
Objective |
The objective of this study is to evaluate the efficacy of routine upfront manual aspiration thrombectomy during PPCI compared with percutaneous coronary intervention alone in patients with STEMI.
Design |
This is a multicenter, prospective, open, international, randomized trial with blinded assessment of outcomes. Patients with STEMI undergoing PPCI are randomized to upfront routine manual aspiration thrombectomy with the Export catheter (Medtronic CardioVascular, Santa Rosa, CA) or to percutaneous coronary intervention alone. The primary outcome is the composite of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or new or worsening New York Heart Association class IV heart failure up to 180 days. The trial uses an event-driven design and will recruit 10,700 patients.
Summary |
The TOTAL trial will determine the effect of routine manual aspiration thrombectomy during PPCI on clinically important outcomes.
Le texte complet de cet article est disponible en PDF.Plan
| Mauricio G. Cohen, MD, served as guest editor for this article. |
|
| Clinical trial registration: ClinicalTrials.gov no. NCT01149044. |
Vol 167 - N° 3
P. 315 - mars 2014 Retour au numéro
Article précédent
- The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: Rationale and design of the SYMPATHY trial
- Eva E. Vink, Esther de Beus, Rosa L. de Jager, Michiel Voskuil, Wilko Spiering, Evert-jan Vonken, G. Ardine de Wit, Kit C.B. Roes, Michiel L. Bots, Peter J. Blankestijn
- DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial
- Robin Hofmann, Stefan K. James, Leif Svensson, Nils Witt, Mats Frick, Bertil Lindahl, Ollie Östlund, Ulf Ekelund, David Erlinge, Johan Herlitz, Tomas Jernberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?